Morningside Venture Investments
Morningside Venture Investments is an investment group that provides industry investments and social responsibility.
Business Model:
Revenue: $45.8M
Employees: 51-200
Rankings
Detailed Morningside Venture Investments Information
Geographic Data
Address: 2-20 Paterson Street
City: Causeway Bay
State: other
Zip:
Country: HK
Financial Info
Stage:
Raised Last:
$0
Raised Total:$1B
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Morningside Venture Investments is an investment group that provides industry investments and social responsibility. It was founded in 1986 and is based in Shanghai, China.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2019 | ZielBio | Series A | 25.1M |
| 11/2021 | EasyExpunctions | Series A | 6.3M |
| 11/2018 | Retrotope | Series C | 20M |
| 3/2021 | Stavvy | Series A | 26.5M |
| 4/2019 | CollegeVine | Series B | 24M |
| 1/2017 | Lighthouse.io | Seed Round | 0 |
| 7/2021 | Medrhythms | Series B | 25M |
| 1/2021 | Innodem Neurosciences | Series A | 6M |
| 5/2021 | Neuroelectrics | Series A | 17.5M |
| 2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 5/2021 | Coin Metrics | Series B | 0 |
| 3/2020 | Sensel | Series A | 0 |
| 1/2021 | New Amsterdam Pharma | Series A | 0 |
| 9/2019 | Inotrem | Series B | 43.1M |
| 3/2021 | Apnimed | Series B | 25M |
| 7/2019 | Rockley Photonics | Series E | 52M |
| 1/2019 | Apic Bio | Series A | 0 |
| 5/2021 | Stealth BioTherapeutics | Post-IPO Equity | 30M |
| 1/2020 | Cyted | Seed Round | 10.5M |
| 9/2019 | Meissa Vaccines | Series A | 30M |
| 1/2011 | Clean Membranes | Series A | - |
| 6/2018 | Triastek | Series A | 15.6M |
| 4/2020 | Stealth BioTherapeutics | Post-IPO Equity | 20M |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 11/2021 | Geneoscopy | Series B | 105M |
| 11/2021 | Generate Biomedicines | Series B | 0 |
| 11/2021 | DeepCure | Series A | 0 |
| 7/2016 | Ignition Design Labs | Series A | 10.3M |
| 3/2021 | Catalant | Venture Round | 35M |
| 6/2018 | ENYO Pharma | Series B | 46.8M |
| 2/2006 | ThingMagic | Equity | 6M |
| 9/2020 | Revolo Biotherapeutics | Series B | 52M |
| 7/2021 | Linus Health | Series B | 55M |
| 8/2017 | Jitjatjo | Seed Round | 4.4M |
| 7/2015 | CloudMosa | Series A | 0 |
| 12/2020 | Tallac Therapeutics | Series A | 62M |
| 10/2022 | Valitor | Series B | 0 |
| 8/2022 | AdvanCell | Series B | 12.5M |
| 1/2020 | Adjuvance Technologies | Series A | 20M |
| 1/2022 | Big Health | Series C | 0 |
| 9/2019 | Medannex Ltd | Series B | 13.5M |
| 1/2022 | Casana | Series B | 0 |
| 10/2021 | BetterUp | Series E | 0 |
| 10/2014 | DNAtriX | Series B | 20M |
| 5/2020 | Atea | Series D | 215M |
| 9/2021 | Homee | Series B | 0 |
| 6/2021 | Triastek | Series B | 0 |
| 11/2016 | CollegeVine | Series A | 3.1M |
| 8/2020 | Prescryptive Health | Series A | 0 |
| 10/2020 | CellCentric | Venture Round | 33M |
| 8/2022 | Epigenic Therapeutics | Seed Round | 0 |
| 3/2022 | Eko | Series C | 0 |
| 8/2020 | F2G | Private Equity Round | 0 |
| 3/2021 | PhoreMost | Series B | 45.3M |
| 4/2017 | CollegeVine | Series A | 3.6M |
| 1/2021 | Rockley Photonics | Venture Round | 65M |
| 7/2020 | neoX Biotech | Venture Round | 10M |
| 6/2020 | Prilenia | Series A | 62.5M |
| 10/2019 | IM Therapeutics | Series A | 10M |
| 9/2020 | Lele Ketang | Series C | 40M |
| 2/2020 | Semios | Venture Round | 75M |
| 1/2022 | Virtue Diagnostics | Series B | 0 |
| 10/2016 | IrisVR | Series A | 8M |
| 4/2017 | Freight Farms | Series B | 6.5M |
| 11/2021 | Block Renovation | Series C | 0 |
| 12/2020 | Curai Health | Series B | 27.5M |
| 8/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 8/2017 | Apellis Pharmaceuticals | Series E | 0 |
| 10/2020 | InCarda Therapeutics | Series C | 30M |
| 7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
| 10/2021 | Exo Therapeutics | Series B | 0 |
| 2/2022 | Curve Health | Series A | 0 |
| 7/2020 | Amylyx Pharmaceuticals | Series B | 0 |
| 6/2017 | Desora | Series A | - |
| 12/2021 | Almond FinTech | Seed Round | 2M |
| 1/2019 | Jitjatjo | Series A | 11M |
| 7/2020 | Vesigen Therapeutics | Series A | 28.5M |
| 10/2019 | Cognoa | Series A | 45.1M |
| 11/2004 | ViOptix | Series C | 0 |
| 11/2022 | Resilience Lab | Series A | 0 |
| 11/2021 | Huckleberry Labs | Series A | 0 |
| 11/2021 | ieso | Series B | 0 |
| 12/2014 | Twelve Springs | Series A | 7M |
| 7/2021 | Fount Bio | Series A | 8.2M |
| 9/2019 | Aural Analytics | Seed Round | 0 |
| 12/2021 | Almond Finance | Seed | 2M |
| 6/2021 | Alentis Therapeutics | Series B | 66.8M |
| 4/2019 | Allysta | Series A | - |
| 3/2022 | Eko | Series C | 0 |
| 2/2022 | Curve Health | Series A | 0 |
| 2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 1/2022 | Casana | Series B | 0 |
| 1/2022 | Big Health | Series C | 0 |
| 1/2022 | Virtue Diagnostics | Series B | 0 |
| 12/2021 | Almond Finance | Seed Round | 0 |
| 11/2021 | ieso | Series B | 0 |
| 11/2021 | Generate Biomedicines | Series B | 0 |
| 11/2021 | Geneoscopy | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
